For Linda Carver of Tampa, Florida, the moment she realized her hearing was failing didn't come at a doctor's office. It came at her granddaughter's 7th birthday party, when she leaned in close, smiled, and nodded — for a full 20 minutes — without understanding a single word the child had said.
She is far from alone. According to the National Institute on Deafness and Other Communication Disorders (NIDCD), roughly 1 in 3 Americans aged 65–74 lives with disabling hearing loss. By age 75, nearly half do. Yet only about 16% of adults who could benefit from a hearing aid actually use one.
Why? After interviewing dozens of patients, audiologists, and AARP advocates, we found the same five reasons over and over:
— What's keeping Americans from treating their hearing loss —
- The price tag. A pair of prescription hearing aids in the U.S. averages $4,600 — and Medicare still doesn't cover them.
- The discomfort. Traditional in-ear models clog the ear canal, cause itching, sweating, and chronic irritation after a few hours.
- The whistling. Cheap amplifiers boost everything — including the rattle of dishes and feedback squeals at the dinner table.
- The stigma. Bulky beige devices behind the ear feel like a public announcement: "I'm getting old."
- The hassle. Tiny batteries that die at the worst moment. Multiple audiologist visits to "tune" the device.
Worse, the consequences of not treating hearing loss go far beyond missed conversations. A landmark 2023 study by Johns Hopkins Bloomberg School of Public Health found that adults with untreated moderate hearing loss are up to 1.94× more likely to develop dementia than peers with normal hearing.
"Untreated hearing loss is associated with a 24% increase in cognitive decline over 6 years."
— Dr. Frank Lin, M.D., Ph.D. · Johns Hopkins University
01.The Turning Point: A Bone-Conduction Breakthrough
Bone-conduction technology isn't new — it was used in U.S. military submarine communications as early as the 1970s. Vibrations travel through the cheekbone directly to the inner ear, completely bypassing the ear canal and even a damaged eardrum.
In late 2024, an audio-engineering team in California adapted that same military-grade transducer for civilian use, paired it with a 16-channel speech-isolation chip, and submitted the prototype — now sold as the Bqyoom X2 — for an independent 14-week trial led by clinical audiologists.
The results, on 312 adults aged 55 to 82 with mild-to-moderate hearing loss, were striking enough that Major U.S. health insurers are now exploring partial reimbursement: